Salivary biomarkers of periodontal disease in response to treatment.

Salivary biomarker development using genomic, proteomic and metabolomic approaches. Genome Med (2012) 1.16

Periodontal disease immunology: 'double indemnity' in protecting the host. Periodontol 2000 (2013) 1.06

Bone remodeling-associated salivary biomarker MIP-1α distinguishes periodontal disease from health. J Periodontal Res (2011) 0.95

Crevicular fluid biomarkers and periodontal disease progression. J Clin Periodontol (2013) 0.94

Recording and surveillance systems for periodontal diseases. Periodontol 2000 (2012) 0.92

Comparison of biomarkers in blood and saliva in healthy adults. Nurs Res Pract (2012) 0.92

Salivary biomarkers associated with gingivitis and response to therapy. J Periodontol (2014) 0.90

Temporal Stability of the Salivary Microbiota in Oral Health. PLoS One (2016) 0.89

Metabolic disease risk in children by salivary biomarker analysis. PLoS One (2014) 0.88

Targeted salivary biomarkers for discrimination of periodontal health and disease(s). Front Cell Infect Microbiol (2015) 0.84

Age-related differences of tooth enamel morphochemistry in health and dental caries. EPMA J (2015) 0.83

Inflammation Biomarkers of Advanced Disease in Nongingival Tissues of Chronic Periodontitis Patients. Mediators Inflamm (2015) 0.83

Salivary biomarkers in a biofilm overgrowth model. J Periodontol (2014) 0.82

Oral fluid based biomarkers in periodontal disease: part 1. Saliva. J Int Oral Health (2014) 0.82

Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health. J Periodontal Implant Sci (2013) 0.79

Patient-Specific Variations in Biomarkers across Gingivitis and Periodontitis. PLoS One (2015) 0.78

Inflammatory Cytokines Interleukin-1β and Tumour Necrosis Factor-α - Novel Biomarkers for the Detection of Periodontal Diseases: a Literature Review. J Oral Maxillofac Res (2016) 0.78

Impact of metronidazole and amoxicillin combination on matrix metalloproteinases-1 and tissue inhibitors of matrix metalloproteinases balance in generalized aggressive periodontitis. Eur J Dent (2015) 0.78

Protein biomarkers of periodontitis in saliva. ISRN Inflamm (2014) 0.78

Effect of periodontal surgery on osteoprotegerin levels in gingival crevicular fluid, saliva, and gingival tissues of chronic periodontitis patients. Dis Markers (2015) 0.76

Hepatocyte growth factor levels in the saliva and gingival crevicular fluid in smokers with periodontitis. Dis Markers (2014) 0.75

Association between vitamin D receptor gene polymorphisms and chronic periodontitis among Libyans. Libyan J Med (2015) 0.75

Evaluation of salivary interleukin-6 in children with early childhood caries after treatment. Contemp Clin Dent (2016) 0.75

Salivary Markers for Periodontal and General Diseases. Dis Markers (2016) 0.75

Development of a standardized flow cytometric method to conduct longitudinal analyses of intracellular CD3ζ expression in patients with head and neck cancer. Oncol Lett (2016) 0.75

Rapid assessment of salivary MMP-8 and periodontal disease using lateral flow immunoassay. Oral Dis (2016) 0.75

Development of a classification system for periodontal diseases and conditions. Ann Periodontol (1999) 12.48

Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature (1986) 5.68

Methods for collecting saliva. Ann N Y Acad Sci (1993) 3.65

The diagnostic applications of saliva--a review. Crit Rev Oral Biol Med (2002) 3.41

Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000 (2004) 2.57

Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc (2006) 2.48

Microfluidic immunoassays as rapid saliva-based clinical diagnostics. Proc Natl Acad Sci U S A (2007) 2.39

Analysis of saliva for periodontal diagnosis--a review. J Clin Periodontol (2000) 2.04

Periodontal disease at the biofilm-gingival interface. J Periodontol (2007) 2.01

Bone remodeling biomarkers of periodontal disease in saliva. J Periodontol (2008) 1.88

Current developments in salivary diagnostics. Biomark Med (2010) 1.83

Non-surgical pocket therapy: mechanical. Ann Periodontol (1996) 1.79

Periodontitis. Ann Periodontol (1999) 1.78

Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol (2009) 1.72

Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood (2000) 1.69

Application of microchip assay system for the measurement of C-reactive protein in human saliva. Lab Chip (2005) 1.67

Saliva as a diagnostic tool for periodontal disease: current state and future directions. Periodontol 2000 (2009) 1.66

Regulation of osteoclast differentiation. Ann N Y Acad Sci (2006) 1.49

Saliva as a diagnostic fluid. BMJ (1992) 1.41

Absence of bleeding on probing. An indicator of periodontal stability. J Clin Periodontol (1990) 1.40

Candidate salivary biomarkers associated with alveolar bone loss: cross-sectional and in vitro studies. FEMS Immunol Med Microbiol (2007) 1.29

Lab-on-a-chip methods for point-of-care measurements of salivary biomarkers of periodontitis. Ann N Y Acad Sci (2007) 1.26

Evaluation of components of gingival crevicular fluid as diagnostic tests. Ann Periodontol (1997) 1.22

Beta-glucuronidase activity in saliva: relationship to clinical periodontal parameters. J Periodontol (2003) 1.21

GCF IL-1beta profiles in periodontal disease. J Clin Periodontol (2002) 1.19

Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes. J Periodontol (2010) 1.17

Macrophage inflammatory protein-1alpha: a salivary biomarker of bone loss in a longitudinal cohort study of children at risk for aggressive periodontal disease? J Periodontol (2009) 1.15

Long-term evaluation of periodontal therapy: I. Response to 4 therapeutic modalities. J Periodontol (1996) 1.12

Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases. Ann N Y Acad Sci (1994) 1.06

Estimation of interleukin-1beta levels in the gingival crevicular fluid in health and in inflammatory periodontal disease. J Periodontal Res (2003) 1.03

Salivary interleukin-1beta concentration and the presence of multiple pathogens in periodontitis. J Clin Periodontol (2009) 1.02

Salivary levels of alpha 2-macroglobulin, alpha 1-antitrypsin, C-reactive protein, cathepsin G and elastase in humans with or without destructive periodontal disease. Arch Oral Biol (1995) 1.01

Comparative proteomic analysis of whole saliva from chronic periodontitis patients. J Proteomics (2010) 1.01

Salivary biomarkers associated with alveolar bone loss. Ann N Y Acad Sci (2007) 1.00

Point detection of pathogens in oral samples. Adv Dent Res (2005) 0.99

Rheumatoid arthritis and salivary biomarkers of periodontal disease. J Clin Periodontol (2010) 0.98

Correlation between salivary IL-1beta levels and periodontal clinical status. Arch Oral Biol (2007) 0.95

Modified-release subantimicrobial dose doxycycline enhances scaling and root planing in subjects with periodontal disease. J Periodontol (2008) 0.95

Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients. J Clin Periodontol (2008) 0.94

In vitro and in vivo activity and pathophysiology of human interleukin-8 and related peptides. Int Rev Exp Pathol (1993) 0.93

Within-subject variability in repeated measures of salivary analytes in healthy adults. J Periodontol (2009) 0.92

Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases. Oral Microbiol Immunol (2005) 0.92

The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis. Arch Immunol Ther Exp (Warsz) (2006) 0.91

Effect of periodontal treatment on the activity of chitinase in whole saliva of periodontitis patients. J Periodontal Res (2002) 0.89

Salivary IgA in response to periodontal treatment. Eur J Oral Sci (2003) 0.87

Salivary monitoring in oral diseases. Ann N Y Acad Sci (1993) 0.86

Smoking affects diagnostic salivary periodontal disease biomarker levels in adolescents. J Periodontol (2010) 0.85

The evaluation of cystatin C, IL-1beta, and TNF-alpha levels in total saliva and gingival crevicular fluid from 11- to 16-year-old children. J Periodontol (2008) 0.85

Gingival crevicular fluid EMAP-II, MIP-1alpha and MIP-1beta levels of patients with periodontal disease. J Clin Periodontol (2005) 0.84

Effect of periodontal treatment on the protein composition of whole and parotid saliva. J Periodontol (1996) 0.82

Salivary levels of Epstein-Barr virus DNA correlate with subgingival levels, not severity of periodontitis. Oral Dis (2009) 0.81

Evaluation of the host response in crevicular fluid, saliva, and blood: implications and applications for the diagnosis of periodontal disease. Periodontal Case Rep (1990) 0.80

Periodontal therapy reduces arginase activity in saliva of patients with chronic periodontitis. Clin Oral Investig (2007) 0.80

Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet (2005) 10.11

Neuropathologic substrate of mild cognitive impairment. Arch Neurol (2006) 6.26

Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the "red complex", a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000 (2005) 3.80

Tooth loss, dementia and neuropathology in the Nun study. J Am Dent Assoc (2007) 3.29

How practicing dentists can shape dental research: The American Association for Dental Research's vision for the future. J Am Dent Assoc (2012) 2.77

Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. Am J Epidemiol (2007) 2.70

Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc (2006) 2.48

Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol (2008) 2.44

Cerebral activation during thermal stimulation of patients who have burning mouth disorder: an fMRI study. Pain (2006) 2.31

Predicting risk of malignancy in adnexal masses. Obstet Gynecol (2010) 2.31

Hippocampal sclerosis in advanced age: clinical and pathological features. Brain (2011) 2.16

Interference of cardiac pacemaker and implantable cardioverter-defibrillator activity during electronic dental device use. J Am Dent Assoc (2010) 2.04

Patterns of colorectal cancer incidence, risk factors, and screening in Kentucky. South Med J (2004) 1.94

Bone remodeling biomarkers of periodontal disease in saliva. J Periodontol (2008) 1.88

Current developments in salivary diagnostics. Biomark Med (2010) 1.83

Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infect Immun (2007) 1.79

Selecting treatment for patients with malignant epidural spinal cord compression-does age matter?: results from a randomized clinical trial. Spine (Phila Pa 1976) (2009) 1.79

Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography. Obstet Gynecol (2013) 1.77

Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation. Gynecol Oncol (2003) 1.75

Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol (2009) 1.73

Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening. Obstet Gynecol (2011) 1.72

Where are the diagnostic codes in dentistry? Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 1.68

Application of microchip assay system for the measurement of C-reactive protein in human saliva. Lab Chip (2005) 1.67

Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease. J Neuropathol Exp Neurol (2009) 1.66

Lifelong bilingualism maintains neural efficiency for cognitive control in aging. J Neurosci (2013) 1.62

Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies. Acta Neuropathol (2011) 1.62

Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. Cancer (2007) 1.61

The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy. Cancer (2009) 1.59

University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Curr Alzheimer Res (2012) 1.52

Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study. Clin Chem (2009) 1.51

Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol (2005) 1.49

NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev (2005) 1.44

Effects of caloric restriction on inflammatory periodontal disease. Nutrition (2008) 1.43

Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol (2013) 1.41

Blood pressure response to transcendental meditation: a meta-analysis. Am J Hypertens (2008) 1.39

Reduced risk of incident AD with elective statin use in a clinical trial cohort. Curr Alzheimer Res (2008) 1.38

Relationships and our profession. Oral Surg Oral Med Oral Pathol Oral Radiol (2013) 1.37

Shared random effects analysis of multi-state Markov models: application to a longitudinal study of transitions to dementia. Stat Med (2007) 1.36

High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J Clin Microbiol (2006) 1.34

Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol (2002) 1.31

JC virus antibody status underestimates infection rates. Ann Neurol (2013) 1.30

Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease. Alzheimers Dement (2012) 1.28

Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells. J Neurovirol (2005) 1.27

Lab-on-a-chip methods for point-of-care measurements of salivary biomarkers of periodontitis. Ann N Y Acad Sci (2007) 1.26

Antithrombotic agents: implications in dentistry. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2002) 1.26

Humoral immune responses in gingival crevice fluid: local and systemic implications. Periodontol 2000 (2003) 1.21

Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment. Neurosci Lett (2008) 1.15

Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain (2013) 1.13

Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort. Neurodegener Dis (2010) 1.08

ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol (2014) 1.07

A novel Brucella isolate in association with two cases of stillbirth in non-human primates - first report. J Med Primatol (2009) 1.07

JC virus detection in bodily fluids: clues to transmission. Clin Infect Dis (2006) 1.06

Association between male gender and cortical Lewy body pathology in large autopsy series. J Neurol (2010) 1.06

Periodontal disease immunology: 'double indemnity' in protecting the host. Periodontol 2000 (2013) 1.06

Focal cerebral ischemia in the TNFalpha-transgenic rat. J Neuroinflammation (2008) 1.04

Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition. J Alzheimers Dis (2011) 1.03

Patterns of salivary analytes provide diagnostic capacity for distinguishing chronic adult periodontitis from health. J Clin Immunol (2012) 1.03

A multi-mode shock tube for investigation of blast-induced traumatic brain injury. J Neurotrauma (2011) 1.02

Vitamin E and all-cause mortality: a meta-analysis. Curr Aging Sci (2011) 1.01

Mild cognitive impairment: statistical models of transition using longitudinal clinical data. Int J Alzheimers Dis (2012) 1.01

Preclinical AD Workgroup staging: pathological correlates and potential challenges. Neurobiol Aging (2011) 0.99

Short- and medium-chain fatty acids exhibit antimicrobial activity for oral microorganisms. Arch Oral Biol (2011) 0.98

Current development of saliva/oral fluid-based diagnostics. Tex Dent J (2010) 0.98

A nonstationary Markov transition model for computing the relative risk of dementia before death. Stat Med (2010) 0.98

Rheumatoid arthritis and salivary biomarkers of periodontal disease. J Clin Periodontol (2010) 0.98

Periodontal disease in Hispanic Americans with type 2 diabetes. J Periodontol (2008) 0.97

Adjusting for mortality when identifying risk factors for transitions to mild cognitive impairment and dementia. J Alzheimers Dis (2013) 0.97

Effects of ignoring baseline on modeling transitions from intact cognition to dementia. Comput Stat Data Anal (2009) 0.95

Modified-release subantimicrobial dose doxycycline enhances scaling and root planing in subjects with periodontal disease. J Periodontol (2008) 0.95

Novel model for multispecies biofilms that uses rigid gas-permeable lenses. Appl Environ Microbiol (2011) 0.94

Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB. J Alzheimers Dis (2009) 0.94

Oral microbial biofilm stimulation of epithelial cell responses. Cytokine (2012) 0.94

Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment. J Clin Microbiol (2005) 0.93

Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care. Methodist Debakey Cardiovasc J (2012) 0.93

Within-subject variability in repeated measures of salivary analytes in healthy adults. J Periodontol (2009) 0.92

Tau is reduced in AD plasma and validation of employed ELISA methods. Am J Neurodegener Dis (2012) 0.92

The effects of a calorie-reduced diet on periodontal inflammation and disease in a non-human primate model. J Periodontol (2008) 0.92

Serum inflammatory mediators in pregnancy: changes after periodontal treatment and association with pregnancy outcomes. J Periodontol (2009) 0.91

Practice effects in a longitudinal, multi-center Alzheimer's disease prevention clinical trial. Trials (2012) 0.90

Salivary biomarkers associated with gingivitis and response to therapy. J Periodontol (2014) 0.90